| Literature DB >> 26712789 |
Clemens Schmeitzl1, Elisabeth Varga2,3, Benedikt Warth4, Karl G Kugler5, Alexandra Malachová6,7, Herbert Michlmayr8, Gerlinde Wiesenberger9, Klaus F X Mayer10, Hans-Werner Mewes11, Rudolf Krska6, Rainer Schuhmacher12, Franz Berthiller13,14, Gerhard Adam15.
Abstract
Increasing frequencies of 3-acetyl-deoxynivalenol (3-ADON)-producing strains of Fusarium graminearum (3-ADON chemotype) have been reported in North America and Asia. 3-ADON is nearly nontoxic at the level of the ribosomal target and has to be deacetylated to cause inhibition of protein biosynthesis. Plant cells can efficiently remove the acetyl groups of 3-ADON, but the underlying genes are yet unknown. We therefore performed a study of the family of candidate carboxylesterases (CXE) genes of the monocot model plant Brachypodium distachyon. We report the identification and characterization of the first plant enzymes responsible for deacetylation of trichothecene toxins. The product of the BdCXE29 gene efficiently deacetylates T-2 toxin to HT-2 toxin, NX-2 to NX-3, both 3-ADON and 15-acetyl-deoxynivalenol (15-ADON) into deoxynivalenol and, to a lesser degree, also fusarenon X into nivalenol. The BdCXE52 esterase showed lower activity than BdCXE29 when expressed in yeast and accepts 3-ADON, NX-2, 15-ADON and, to a limited extent, fusarenon X as substrates. Expression of these Brachypodium genes in yeast increases the toxicity of 3-ADON, suggesting that highly similar genes existing in crop plants may act as susceptibility factors in Fusarium head blight disease.Entities:
Keywords: 15-acetyl-deoxynivalenol; 3-acetyl-deoxynivalenol; Fusarium graminearum; enzymatic cleavage; monocot; trichothecene metabolism
Mesh:
Substances:
Year: 2015 PMID: 26712789 PMCID: PMC4728528 DOI: 10.3390/toxins8010006
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1Deacetylation of (a) 3-acetyl-deoxynivalenol (3-ADON) and (b) 15-acetyl-deoxynivalenol (15-ADON) to deoxynivalenol (DON) by B. distachyon (Bd21) cell suspension cultures. Shown is the concentration measured in the medium.
List of putative CXEs identified via protein BLAST search utilizing the MIPS PlantsDB. BdCXE clusters are shaded in grey. Gene models enclosed in brackets are not enclosed in the identity-based neighborhood joining tree (Supplemental Figure S5). For the RT-assay, Bd21 seedlings were incubated with 10 mg/L 3-ADON.
| Gene Name | Gene Locus | * | Predicted cDNA Length (Bases) | Predicted Introns | Conserved Site Changed | Confidence Class | Results RT-Assay |
|---|---|---|---|---|---|---|---|
| (Bradi1g06240.1) | 1557 | 2 | - | 3 | constitutive | ||
| Bradi1g06241.1 ‡ | 1014 | 0 | - | - | |||
| Bradi1g17780.1 | 1038 | 0 | - | 5 | <LOD | ||
| (Bradi1g19715.1) | 1935 | 3 | - | 3 | n.t. | ||
| Bradi1g19713.1 ‡ | 1032 | 0 | - | - | n.t. | ||
| Bradi1g19716.1 ‡ | 1068 | 0 | H316del | - | n.t. | ||
| Bradi1g19720.1 | 1083 | 0 | - | 5 | n.t. | ||
| Bradi1g19730.1 | 1047 | 0 | - | 4 | low constitutive expression | ||
| (Bradi1g19750.1) | 1083 | 0 | - | 5 | constitutive | ||
| Bradi1g19750.2 ‡ | 1233 | 1 | - | - | constitutive | ||
| Bradi1g19760.1 | 1011 | 0 | - | 4 | <LOD | ||
| Bradi1g21890.1 | 1038 | 0 | - | 5 | n.t. | ||
| Bradi1g38325.1 ‡ | 1053 | 0 | - | - | - | ||
| (Bradi1g45925.1) | 942 | 0 | - | 5 | n.t. | ||
| Bradi1g45921.1 ‡ | 2643 | 11 | - | - | - | ||
| Bradi1g45930.1 | 987 | 0 | - | 5 | repressed | ||
| Bradi1g45945.1 | 924 | 0 | - | 4 | n.t. | ||
| Bradi1g45960.1 | 999 | 0 | - | 5 | induced | ||
| Bradi1g48173.1 ‡ | 1362 | 3 | G207S | - | - | ||
| Bradi1g48203.1 ‡ | 1107 | 1 | - | - | - | ||
| Bradi1g50705.1 ‡ | 1293 | 1 | - | - | - | ||
| Bradi1g56807.1 | 1008 | 0 | - | 4 | n.t. | ||
| (Bradi1g56817.1) | 984 | 0 | H296R | 3 | n.t. | ||
| Bradi1g56817.2 ‡ | 990 | 0 | - | - | n.t. | ||
| Bradi1g56830.1 | 1086 | 0 | - | 4 | <LOD | ||
| Bradi1g56860.1 | 1092 | 0 | - | 4 | repressed | ||
| Bradi1g56870.1 | 1017 | 0 | - | 5 | low expression, repressed | ||
| Bradi1g56910.1 | 1038 | 0 | - | 4 | <LOD | ||
| Bradi1g67600.1 | 1116 | 0 | - | 5 | <LOD | ||
| Bradi1g67930.1 | 999 | 0 | S164H, H293Y | 5 | <LOD | ||
| Bradi1g74240.1 | 984 | 0 | D296C | 5 | n.t. | ||
| Bradi2g01817.1 | 987 | 0 | - | 4 | n.t. | ||
| Bradi2g25470.1 | 1062 | 0 | - | 5 | induced | ||
| Bradi2g25600.1 | 1068 | 1 | H328I | 5 | constitutive | ||
| Bradi2g27300.1 | 1026 | 0 | - | 5 | constitutive | ||
| Bradi2g57920.1 | 1209 | 1 | - | 5 | <LOD | ||
| Bradi3g21747.1 | 1053 | 0 | - | 4 | n.t. | ||
| Bradi3g38040.1 | 984 | 0 | - | 5 | constitutive | ||
| Bradi3g38045.1 | 990 | 0 | - | 5 | n.t. | ||
| Bradi3g38050.1 | 951 | 0 | - | 5 | n.t. | ||
| Bradi3g38060.1 | 1113 | 0 | - | 5 | n.t. | ||
| Bradi3g38070.1 | 1002 | 0 | - | 5 | n.t. | ||
| Bradi3g38080.1 | 1119 | 0 | - | 5 | <LOD | ||
| (Bradi3g38090.1) | 1116 | 0 | - | 5 | <LOD | ||
| Bradi3g38090.2 ‡ | 1257 | 0 | - | - | <LOD | ||
| Bradi3g42207.1 | 1089 | 0 | H311F | 4 | n.t. | ||
| Bradi3g46450.1 | 951 | 0 | - | 4 | constitutive | ||
| Bradi3g46460.1 | 957 | 0 | - | 4 | <LOD | ||
| Bradi4g12370.1 | 1032 | 0 | - | 4 | n.t. | ||
| (Bradi4g12370.1) ‡ | 957 | 0 | D263del | - | n.t. | ||
| Bradi4g21690.1 | 1065 | 0 | - | 5 | <LOD | ||
| Bradi4g21700.1 | 1047 | 0 | - | 5 | <LOD | ||
| Bradi4g24773.1 ‡ | 1380 | 0 | - | - | n.t. | ||
| Bradi4g32080.1 | 966 | 0 | - | 5 | repressed | ||
| Bradi4g32080.2 ‡ | 1113 | 0 | - | - | repressed | ||
| Bradi4g32300.1 | 1221 | 0 | - | 5 | repressed | ||
| Bradi4g32310.1 | 1071 | 0 | - | 5 | n.t. | ||
| Bradi4g32320.1 | 954 | 0 | - | 5 | low constitutive expression | ||
| (Bradi4g32330.1) | 969 | 0 | D264C | 5 | repressed | ||
| Bradi4g32330.2 ‡ | 1110 | 0 | D311C | repressed | |||
| Bradi4g32340.1 | 1149 | 0 | - | 5 | constitutive | ||
| Bradi4g32350.1 | 1002 | 0 | - | 5 | low constitutive expression | ||
| Bradi4g32360.1 | 972 | 0 | - | 5 | constitutive | ||
| Bradi4g39410.1 | 1062 | 0 | HGGdel | 3 | <LOD | ||
| Bradi4g39410.2 ‡ | 1311 | 1 | - | - | <LOD | ||
| Bradi5g08900.1 | 1041 | 0 | - | 4 | n.t. | ||
| Bradi5g11800.1 | 942 | 0 | - | 5 | n.t. |
* Orientation of clustered genes: ↓, forward; ↑, reverse; LOD, limit of detection; n.t., not tested; ‡ Phytozome prediction, confidence classes in “MIPS PlantsDB” according to [30] (0 to 5; 5: highest probability based on available expressed sequence tags and homologous loci in other monocots).
Figure 2Activity of BdCXEs expressed in yeast strain YZGA2274 (ayt1 pdr5,10,15 rps11a) (a) expressing the indicated genes spotted in three dilutions on synthetic complete medium (SC) plates lacking uracil and containing the indicated amounts of toxin; (b) hydrolysis of 12 mg/L 3-acetyl-deoxynivalenol (3-ADON) into deoxynivalenol (DON) and (c) 15-acetyl-deoxynivalneol (15-ADON, 12 mg/L) to DON and the release into the supernatant by protein extracts of transformed yeast expressing BdCXE29, BdCXE52 and Tri8 from a 15-ADON chemotype Fusarium graminearum strain (Tri8-15AD) or a 3-ADON chemotype strain (Tri8-3AD).
Hydrolysis of acetylated trichothecenes in a yeast protein extract expressing BdCXE29 or BdCXE52 into the deacetylated metabolite.
| Substrate | Product | BdCXE29 | BdCXE52 | ||
|---|---|---|---|---|---|
| 2 h | 24 h | 2 h | 24 h | ||
| 3-acetyldeoxynivalenol | deoxynivalenol | 77% | 100% | 5% | 34% |
| 15-acetyldeoxynivalenol | deoxynivalenol | 70% | 100% | 0% | 4% |
| T-2 toxin | HT-2 toxin | 100% | 100% | 0% | 0% |
| trichothecin | trichothecolone | 0% | 0% | 0% | 0% |
| HT-2 toxin | T-2 triol | 0% | 0% | 0% | 0% |
| fusarenon X | nivalenol | <1% | 4% | 0% | <1% |
| NX-2 | NX-3 | 91% | 100% | 3% | 17% |
Structure of selected trichothecenes.
| R1 | R2 | R3 | R4 | R5 | |
|---|---|---|---|---|---|
| 3-acetyldeoxynivalenol | –OAc | –H | –OH | –OH | =O |
| 15-acetyldeoxynivalenol | –OH | –H | –OAc | –OH | =O |
| deoxynivalenol | –OH | –H | –OH | –OH | =O |
| trichothecin | –H | –OIsocrot | –CH3 | –H | =O |
| trichothecolone | –H | –OH | –CH3 | –H | =O |
| T-2 toxin | –OH | –OAc | –OAc | –H | –OIsoval |
| HT-2 toxin | –OH | –OH | –OAc | –H | –OIsoval |
| T-2 triol | –OH | –OH | –OH | –H | –OIsoval |
| fusarenon X | –OH | –OAc | –OH | –OH | =O |
| nivalenol | –OH | –OH | –OH | –OH | =O |
| NX-2 | –OAc | –H | –OH | –OH | –H |
| NX-3 | –OAc | –H | –OH | –OH | –H |
OIsoval, isovaleryl group; OIsocrot, isocrotonyl group.
Kinetic constants of BdCXE29 determined at 25 °C and pH 7.5.
| Substrate | Kinetic Constant | |||
|---|---|---|---|---|
| 4-nitrophenylacetate | 1860 ± 288 | 48 ± 4 | 0.988 | - |
| 4-nitrophenylbutyrate | 5530 ± 757 | 1.7 ± 0.2 | 0.996 | - |
| 15-acetyl-deoxynivalenol | 421 ± 70 | 3.4 ± 0.2 | 0.973 | - |
| 3-acetyl-deoxynivalenol | 89 ± 26 | 1.6 ± 0.2 | 0.939 | 1800 ± 490 |
K, Michaelis constant; Vmax, maximum reaction velocity; R2, coefficient of determination; K, inhibitory constant.
Figure 3Kinetic characterization (specific activity) of BdCXE29 with (a) 4-nitrophenylacetate (4-NPA); (b) 4-nitrophenylbutyrate (4-NPB); (c) 3-acetyl-deoxynivalenol (3-ADON) and (d) 15-acetyl-deoxynivalenol (15-ADON) as the substrate.
Mass spectrometric parameters used for the determination of the mycotoxins.
| Analyte | Precursor Ion (DP) | Quantifier (CE; CXP) | Qualifier (CE; CXP) |
|---|---|---|---|
| deoxynivalenol | 355.1 (−40) | 59.2 (−40; −8) | 265.2 (−22; −13) |
| 3-acetyl-deoxynivalenol | 397.3 (−40) | 59.2 (−38; −8) | 307.1 (−20; −7) |
| 15-acetyl-deoxynivalenol | 397.3 (−40) | 59.2 (−38; −8) | 337.1 (−10; −7) |
| nivalenol | 371.1 (−45) | 59.1 (−42; −7) | 281.1 (−22; −15) |
| fusarenon X | 413.3.(−40) | 59.1 (−40; −9) | 262.9 (−22; −16) |
| HT-2 toxin | 442.2 (46) | 263.1 (21; 19) | - |
| 447.4 (101) | - | 345.1 (27; 20) | |
| T-2 toxin | 484.3 (56) | 215.2 (29; 18) | 185.1 (31; 11) |
| T-2 tetraol | 316.2 (31) | 215.3 (13; 16) | 281.4 (13; 8) |
| T-2 triol | 400.2 (41) | 215.2 (17; 12) | 281.3 (13; 16) |
| NX-2 | 383.1 (−45) | 59.0 (−36; −7) | 323 (−14; −7) |
| NX-3 | 341.1 (−50) | 59.0 (−36; −7) | 281 (−14; −7) |
DP, declustering potential; CE, collision energy; CXP, cell exit potential.